Prevalence and recovery of dysphonia in COVID-19 patients requiring intensive care treatment

被引:1
作者
Clayton, Nicola A. [1 ,2 ,3 ,4 ,10 ]
Freeman-Sanderson, Amy [5 ,6 ,7 ,8 ,9 ]
Walker, Elizabeth [5 ,6 ]
机构
[1] Concord Repatriat Gen Hosp, Speech Pathol Dept, Sydney, NSW, Australia
[2] Concord Repatriat Gen Hosp, Intens Care Unit, Sydney, NSW, Australia
[3] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[4] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia
[5] Royal Prince Alfred Hosp, Speech Pathol Dept, Sydney, NSW, Australia
[6] Royal Prince Alfred Hosp, Intens Care Unit, Sydney, NSW, Australia
[7] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia
[8] George Inst Global Hlth, Crit Care Div, Sydney, NSW, Australia
[9] Monash Univ, Australian & New Zealand Intens Care Res Ctr ANZIC, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[10] Concord Repatriat Gen Hosp, Speech Pathol Dept, Bldg 42,Hosp Rd, Concord, NSW 2139, Australia
关键词
COVID-19; SARS-CoV2; Dysphonia; Critically ill; Recovery;
D O I
10.1016/j.aucc.2023.07.043
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Dysphonia and laryngeal pathology are considerable issues in patients hospitalised with COVID-19 with prevalence rates cited between 29% and 79%. Most studies currently are limited to reporting single-institution data with many retrospective. Objectives: The aims of this study were to prospectively explore the following: (i) prevalence; (ii) treatment; and (iii) recovery pattern and outcomes for dysphonia, in patients with COVID-19 requiring intensive care unit (ICU) treatment. Methods: Patients admitted to 26 ICUs over 12 months, diagnosed with COVID-19, treated for survival, and seen by speech-language pathology for clinical voice assessment were considered. Demographic, medical, speech-language pathology treatment, and voice outcome data (grade, roughness, breathiness, asthenia, strain [GRBAS]) were collected on initial consultation and continuously monitored throughout the hospital admission. Findings: Two-hundred and thirty five participants (63% male, median age = 58 yrs) were recruited. Median mechanical ventilation duration and ICU and hospital lengths of stay (LOSs) were 16, 20, and 42 days, respectively. Dysphonia prevalence was 72% (170/235), with 22% (38/170) exhibiting profound impairment (GRBAS score = 3). Of those with dysphonia, rehabilitation was provided in 32% (54/170) cases, with dysphonia recovery by hospital discharge observed in 66% (112/170, median duration = 35 days [interquartile range = 21-61 days]). Twenty-five percent (n = 42) of patients underwent nasendoscopy: oedema (40%, 17/42), granuloma (31%, 13/42), and vocal fold palsy/paresis (26%, 11/42). Presence of dysphonia was inversely associated with the number of intubations (p = 0.002), intubation duration (p = 0.037), ICU LOS (p = 0.003), and hospital LOS (p = 0.009). Conversely, duration of dysphonia was positively associated with the number of intubations (p = 0.012), durations of intubation (p = 0.000), tracheostomy (p = 0.004), mechanical ventilation (p = 0.000), ICU LOS (p = 0.000), and hospital LOS (p = 0.000). More severe dysphonia was associated with younger age (p = 0.045). Proning was not associated with presence (p = 0.075), severity (p = 0.164), or duration (p = 0.738) of dysphonia. Conclusions: Dysphonia and laryngeal pathology are common in critically ill patients with COVID-19 and are associated with younger age and protracted recovery in those with longer critical care interventions. Crown Copyright (c) 2023 Published by Elsevier Ltd on behalf of Australian College of Critical Care Nurses Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).
引用
收藏
页码:151 / 157
页数:7
相关论文
共 50 条
  • [31] Prevalence and Risk Factor Analysis of Post-Intensive Care Syndrome in Patients with COVID-19 Requiring Mechanical Ventilation: A Multicenter Prospective Observational Study
    Hatakeyama, Junji
    Inoue, Shigeaki
    Liu, Keibun
    Yamakawa, Kazuma
    Nishida, Takeshi
    Ohshimo, Shinichiro
    Hashimoto, Satoru
    Kanda, Naoki
    Maruyama, Shuhei
    Ogata, Yoshitaka
    Kawakami, Daisuke
    Shimizu, Hiroaki
    Hayakawa, Katsura
    Tanaka, Aiko
    Oshima, Taku
    Fuchigami, Tatsuya
    Yawata, Hironori
    Oe, Kyoji
    Kawauchi, Akira
    Yamagata, Hidehiro
    Harada, Masahiro
    Sato, Yuichi
    Nakamura, Tomoyuki
    Sugiki, Kei
    Hakozaki, Takahiro
    Beppu, Satoru
    Anraku, Masaki
    Kato, Noboru
    Iwashita, Tomomi
    Kamijo, Hiroshi
    Kitagawa, Yuichiro
    Nagashima, Michio
    Nishimaki, Hirona
    Tokuda, Kentaro
    Nishida, Osamu
    Nakamura, Kensuke
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [32] Prevalence of dysphonia due to COVID-19 at Salahaddin General Hospital, Tikrit City, Iraq
    Al-Ani, Raid M.
    Rashid, Rasheed Ali
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2021, 42 (05)
  • [33] Intensive care therapy for COVID-19
    Becker, Andre P.
    Mang, Sebastian
    Rixecker, Torben
    Lepper, Philipp M.
    PNEUMOLOGIE, 2024, 78 (05): : 330 - 345
  • [34] Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID-19 according to patients' oxygen requirements
    Tortajada, Cecilia
    Colomer, Enrique
    Andreu-Ballester, Juan C.
    Esparcia, Ana
    Oltra, Carmina
    Flores, Juan
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1817 - 1823
  • [35] Intensive care management of patients with COVID-19: a practical approach
    Hajjar, Ludhmila Abrahao
    Costa, Isabela Bispo Santos da Silva
    Rizk, Stephanie Itala
    Biselli, Bruno
    Gomes, Brenno Rizerio
    Bittar, Cristina Salvadori
    de Oliveira, Gisele Queiroz
    de Almeida, Juliano Pinheiro
    de Oliveira Bello, Mariana Vieira
    Garzillo, Cibele
    Leme, Alcino Costa
    Elena, Moizo
    Val, Fernando
    de Almeida Lopes, Marcela
    Lacerda, Marcus Vinicius Guimaraes
    Ramires, Jose Antonio Franchini
    Kalil Filho, Roberto
    Teboul, Jean-Louis
    Landoni, Giovanni
    ANNALS OF INTENSIVE CARE, 2021, 11 (01)
  • [36] Factors affecting mortality in COVID-19 patients in intensive care
    Moralar, Dondu Genc
    Turkmen, Aygen Ulku
    Gokcenoglu, Huseyin
    Alci, Natavan
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2022, 28 (09): : 1229 - 1237
  • [37] A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19
    Ko, Justine J.
    Wu, Clay
    Mehta, Neha
    Wald-Dickler, Noah
    Yang, Wei
    Qiao, Renli
    JOURNAL OF INTENSIVE CARE MEDICINE, 2021, 36 (06) : 673 - 680
  • [38] Intensive care management of patients with COVID-19: a practical approach
    Ludhmila Abrahão Hajjar
    Isabela Bispo Santos da Silva Costa
    Stephanie Itala Rizk
    Bruno Biselli
    Brenno Rizerio Gomes
    Cristina Salvadori Bittar
    Gisele Queiroz de Oliveira
    Juliano Pinheiro de Almeida
    Mariana Vieira de Oliveira Bello
    Cibele Garzillo
    Alcino Costa Leme
    Moizo Elena
    Fernando Val
    Marcela de Almeida Lopes
    Marcus Vinícius Guimarães Lacerda
    José Antonio Franchini Ramires
    Roberto Kalil Filho
    Jean-Louis Teboul
    Giovanni Landoni
    Annals of Intensive Care, 11
  • [39] Incidence of unscheduled removal of invasive devices in patients with COVID-19 in intensive care
    Arias-Rivera, Susana
    Jareno-collado, Raquel
    Sanchez-Sanchez, Maria del Mar
    Frutos-Vivar, Fernando
    ENFERMERIA INTENSIVA, 2025, 36 (02):
  • [40] Treatment for COVID-19 patients in Vietnam: Analysis of time-to-recovery
    Khuong Quynh Long
    Hoang Hong Hanh
    Tran Thi Tuyet Hanh
    La Ngoc Quang
    Hoang Van Minh
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2020, 13 (09) : 397 - 401